Mesa Laboratories, Inc.
MLAB
$61.66
-$1.43-2.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 166.66% | -324.46% | -148.89% | 1.18% | 101.33% |
| Total Depreciation and Amortization | -20.54% | 36.38% | -9.41% | 11.03% | -13.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -132.94% | -76.52% | 520.37% | -20.02% | -99.12% |
| Change in Net Operating Assets | -182.09% | 171.85% | 159.31% | -1,677.22% | -103.95% |
| Cash from Operations | -85.05% | -31.31% | 249.82% | -50.94% | -16.61% |
| Capital Expenditure | -33.29% | 6.89% | 54.53% | -100.67% | -66.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -0.20% | -23.86% | 54.53% | -100.67% | -309.15% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | 58.53% | -84.02% | -31.07% | 90.82% | -604.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.34% | -0.12% | -0.35% | -0.35% | 0.12% |
| Other Financing Activities | -1,337.30% | 4,190.00% | 106.51% | 69.99% | -414.07% |
| Cash from Financing | 47.96% | -52.81% | -23.08% | 8.59% | 27.17% |
| Foreign Exchange rate Adjustments | 66.78% | 319.51% | -141.33% | 666.86% | 54.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -66.22% | -154.92% | 260.07% | -1,702.71% | 2,680.00% |